Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicenter, Open-Label, Single-Arm Clinical Trial to Evaluate the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen in Women of Childbearing Potential

NCT07714616 is registered in ClinicalTrials.gov with Eurofarma Laboratorios S.A. as lead sponsor.

NCT NCT07714616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07714616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicenter, Open-Label, Single-Arm Clinical Trial to Evaluate the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen in Women of Childbearing Potential
Lead sponsor
Eurofarma Laboratorios S.A.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
May 31, 2027
Completion date
May 31, 2030
Enrollment
1,600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contraception